Modern biotechnology has not demonstrated the scale neutrality needed to serve smallholder-dominated agroecosystems, due to a combination of the kinds of traits and restrictions that come from the predominant intellectual property rights instruments used in their commercialisation, as well as the focus on a small number of major crop species